← Back to overview

DXCM DexCom, Inc.

Health Care Equipment · $71.54 +1.50%
Price Alert:
Price & Volume
RSI (14)
MACD (12, 26, 9)

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
44.8
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
72.72 / 71.50 / —
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
0.68 / 1.05
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
30.7
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
27.61B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
54.11 – 89.98
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

DexCom, Inc. is trading at $71.54, +1.50% versus the previous close. The price sits roughly in the middle of its 52-week range.
RSI is in a neutral range — no strong overbought/oversold signal.
MACD is below its signal line — momentum currently leans negative.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

DexCom (DXCM) Earnings Expected to Grow: Should You Buy?
Zacks · 2026-07-23 14:00
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
Business Wire · 2026-07-22 21:15
Dexcom Insider Sold Shares Worth $2,041,999, According to a Recent SEC Filing
MT Newswires · 2026-07-21 21:03
Are Medical Stocks Lagging DexCom (DXCM) This Year?
Zacks · 2026-07-21 13:40
2 Cash-Heavy Stocks on Our Buy List and 1 We Avoid
StockStory · 2026-07-21 11:02
Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating
MT Newswires · 2026-07-16 13:12
What Investors Don’t Understand About Abbott Laboratories
24/7 Wall St. · 2026-07-16 11:40
Mizuho Adjusts Price Target on DexCom to $90 From $85, Maintains Outperform Rating
MT Newswires · 2026-07-15 15:11
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.